BRIEF-Biogen and Abbvie receive positive opinion from the CHMP on zinbryta
April 29, 2016 at 08:03 AM EDT
* Biogen and abbvie receive positive opinion from the chmp on zinbryta(tm) (daclizumab) for treatment of multiple sclerosis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.